FDA figuratively paints a therapeutic landscape when it considers whether to withdraw an accelerated approval drug with an overdue confirmatory trial. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
